Pre-treatment risk stratification of prostate cancer patients: A critical review. - Wikidata - wikimedia - TriplyDB

Pre-treatment risk stratification of prostate cancer patients: A critical review.

Pre-treatment risk stratification of prostate cancer patients: A critical review.

http://www.wikidata.org/entity/Q34268868

about

Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study Patterns of care and treatment trends for Canadian men with localized low-risk prostate cancer: an analysis of provincial cancer registry data Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer Clinical management and burden of prostate cancer: a Markov Monte Carlo model.Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.Novel concepts for risk stratification in prostate cancer.Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer.Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate Cancer The context of prostate cancer genomics in personalized medicine.Efficiency of pretreatment risk stratification systems for prostate cancer in a Japanese population treated with radical prostatectomy.Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer.Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer.The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer.Outcomes of treatment in men with prostate cancer at the cancer centre Bahamas.Genetics and biology of prostate cancer Prolaris Cell Cycle Progression Test for Localized Prostate Cancer: A Health Technology Assessment

P2860

Q28596648-0C8B4295-FBC5-45D1-B32E-FFA1B765E555 Q31056768-727BE617-DD89-4595-B701-9699033D6262 Q33599365-38731402-0194-4610-8288-F56FC59E1B83 Q33696684-D0AEF116-6E56-493F-8A86-C92413F61E79 Q34634410-8AF3F88B-F113-4016-A3B8-A76952A379A0 Q37113204-7DF81AB4-D833-43CF-9EB5-CB67217DE38A Q37658406-8C4CAC2D-C009-4985-BD55-67B20A6300E8 Q37708177-B9BF07E6-9FA9-46F1-844F-E818B6A137B9 Q37718438-297A165E-2FAB-4D7B-A78E-032677B25E08 Q38311505-FE122C20-8D12-4866-9D2F-A4ABFE28F134 Q38356614-F541AA12-73D3-4A36-A298-705868C5E383 Q38394519-780480E2-559A-48B2-81FD-77BC8133337B Q38946078-8009725C-93B4-4C26-A336-57A0FA2DF162 Q38984178-FA860387-6457-4CF9-96DF-CCB4463EA39C Q41839243-7104869E-651E-47E1-8D7F-4DA7C5A487F9 Q44373070-D0F0E387-F05A-4678-BAD4-9E3A91C75BD7 Q47187546-C91D53BF-D03C-4E40-8E91-6A6D73514322 Q48105677-E7567140-9E65-4835-88AC-033D2F06B8ED Q48187737-1400F7C9-3C2F-40EF-8735-88C98CF6B965 Q48210693-8B6E1D58-065F-4BF9-9C81-5F6AC40E187B Q50231169-D521D717-E023-4175-B8C0-634170213D7A Q57106917-939D1760-8EB3-4431-A9AF-4197EB435A28 Q57117462-075B7BFD-342F-4137-9C55-4F99AE46CF62

P2860

Pre-treatment risk stratification of prostate cancer patients: A critical review.

http://www.wikidata.org/entity/Q34268868

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@ast

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@en

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@nl

type

label

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@ast

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@en

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@nl

prefLabel

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@ast

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@en

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@nl

P1433

Q34268868-502698DB-A4F8-42E6-AD1D-8A7787B0F402

P1476

Q34268868-9618FC2E-DFA1-4B3E-B269-017C7D45A6BE

P2093

Q34268868-27F66B8F-3783-4363-8F4A-040144A079DB

Q34268868-53CD4A56-D264-4515-B310-13C5742B6F06

Q34268868-67EF42A3-8C50-4C8E-A153-7CA719E715CE

Q34268868-81F1192F-C089-4733-8A4F-2FF1D58A75DF

Q34268868-B0632FDE-4E12-4ECD-B317-9342DC1CF93D

Q34268868-BC386DDD-897D-4DDC-BDE5-11A5978FD6E0

Q34268868-C0829B51-CBCF-4629-AD56-5CDFEF01F8DD

Q34268868-EA48CD40-6388-49D4-947A-04F166B075CA

P2860

Q34268868-0710F1AA-129C-48A7-BACA-5112F5447D57

Q34268868-0A0803E0-5A63-4344-86A5-658B095322F1

Q34268868-10A7ABC3-2BCD-49ED-A753-6D6BE2ACB164

Q34268868-188928EC-2615-4D51-871C-104EBD8AAAD9

Q34268868-1A3AC189-FFD6-4432-B3C5-53238AE062B7

Q34268868-2EA4784C-DCA8-45F4-AD38-F4DB29F4D0FA

Q34268868-35199502-5076-4D57-94DC-C6B91A874740

Q34268868-3ED353A9-267C-49A1-AB51-F39CC05FDAD2

Q34268868-4D88A44C-F5AE-45A7-AE08-3EC467DF010B

Q34268868-50DFC83B-93A7-41D3-9FB8-7B024AF04B3F

P304

Q34268868-25A67C8F-234C-46C3-B2B5-2179D021C9D9

P31

Q34268868-2F96C1FD-C02B-4C46-9209-70154047907A

P356

Q34268868-ADD1740E-5814-4444-A022-56DB7FEB3993

P433

Q34268868-6835B7B8-4A47-4B00-A629-6AF1A3733FB9

P478

Q34268868-9D354A86-5F0A-4C01-ACDC-18E4380586A4

P577

Q34268868-486E1D15-D39C-4AAB-8DB2-BC7E5FEE487A

P5875

Q34268868-118C2861-CD66-45FB-A458-C3182862FC68

P698

Q34268868-3D81A8A5-05B8-4B31-BD19-DC9478DDEA3F

P932

Q34268868-6E5A031E-8513-4429-9DF7-B36E5169FE39

P356

P1433

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

P1476

Pre-treatment risk stratification of prostate cancer patients: A critical review.

@en

P2093

Genitourinary Radiation Oncologists of Canada

http://www.w3.org/2001/XMLSchema#string

George Rodrigues

http://www.w3.org/2001/XMLSchema#string

Himu Lukka

http://www.w3.org/2001/XMLSchema#string

Juanita Crook

http://www.w3.org/2001/XMLSchema#string

Luis Souhami

http://www.w3.org/2001/XMLSchema#string

Michael Brundage

http://www.w3.org/2001/XMLSchema#string

Padraig Warde

http://www.w3.org/2001/XMLSchema#string

Tom Pickles

http://www.w3.org/2001/XMLSchema#string

P2860

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk.

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.

Controversies in prostate cancer radiotherapy: consensus development.

Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation.

NCCN clinical practice guidelines in oncology: prostate cancer.

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Guideline for the management of clinically localized prostate cancer: 2007 update.

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

P304

121-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5489/CUAJ.11085

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224284736

http://www.w3.org/2001/XMLSchema#string

P698

22511420

http://www.w3.org/2001/XMLSchema#string

P932

3328553

http://www.w3.org/2001/XMLSchema#string